Piper Jaffray & Co. »

Biomarin Pharma Inc convertible/ shares owned by Piper Jaffray & Co.

Quarter-by-quarter ownership of Biomarin Pharma Inc convertible/ shares owned by Piper Jaffray & Co. from 13F filings

Historical chart of Piper Jaffray & Co. investment in Biomarin Pharma Inc convertible/

Tip: Access up to 7 years of quarterly data

All positions including Biomarin Pharma Inc convertible/ held by Piper Jaffray & Co. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biomarin Pharma Inc convertible/ by Piper Jaffray & Co.

Quarter filed Position value Share count Share price at filing
2024-06-30 $21M 22M 0.99

More positions owned by Piper Jaffray & Co.

Eagle Bulk Shipping Note 5.000% 8/0 (Principal)
Jazz Investments I Note 1.500% 8/1 (Principal)
Biomarin Pharmaceutical Note 0.599% 8/0 (Principal)
Pennymac Corp Note 5.500%11/0 (Principal)
Turning Pt Brands Note 2.500% 7/1 (Principal)
Redwood Trust Note 5.625% 7/1 (Principal)
Chegg Note 0.125% 3/1 (Principal)
Prospect Cap Corp Note 6.375% 3/0 (Principal)
Arbor Realty Trust Note 7.500% 8/0 (Principal)
Fiverr Intl Note 11/0 (Principal)
Blackline Note 0.125% 8/0 (Principal)
Palo Alto Networks Note 0.375% 6/0 (Principal)
Shattuck Labs (STTK)
I3 Verticals Note 1.000% 2/1 (Principal)
Profrac Hldg Corp Class A Com (ACDC)

View all positions for Piper Jaffray & Co.

Top funds holding Biomarin Pharma Inc convertible/

Osterweis Capital Management
OZ Management
Millennium Management
Lazard Asset Management
Glazer Capital
Citigroup
Aviva
Tenor Capital Management
Piper Jaffray & Co.
Partner Fund Management
Jpmorgan Chase & Co
Thrivent Financial for Lutherans
State Street Corporation
Branch Banking & Trust Company
Kohlberg Kravis Roberts & Co

View all funds holding Biomarin Pharma Inc convertible/